首页>
外国专利>
METABOLOMIC PREDICTION OF CONGENITAL HEART DEFECT DURING PREGNANCY, NEWBORN AND PEDIATRIC STAGES
METABOLOMIC PREDICTION OF CONGENITAL HEART DEFECT DURING PREGNANCY, NEWBORN AND PEDIATRIC STAGES
展开▼
机译:妊娠,新生儿和小儿阶段先天性心脏病的代谢组学预测
展开▼
页面导航
摘要
著录项
相似文献
摘要
Particular aspects of the invention are methods for assaying metabolite levels in samples from a patient during pregnancy using nuclear magnetic resonance and direct flow injection mass spectrometry. In various methods, the assayed metabolites may be acylcarnitine or one or more of C3-OH (hydroxypropionylcarnitine), C5-OH (C3DC), C10, C5:1-DC (glutaconylcarnitine), C14:1-OH (hydroxytetradecenoylcarnitine) and C14:2-OH. One or more methods also may include measuring nuchal translucency of the fetus. Other methods relate to predicting fetal congenital heart defects in a fetus.
展开▼